Ching-Ann Liu
Impact in
-
- Glioma Diagnosis and Treatment
Papers in
-
- CRISPR and Genetic Engineering 3
- Pluripotent Stem Cells Research 3
- Genetics 4
- Glioma Diagnosis and Treatment 3
- Co-authors
- Horng‐Jyh Harn (13 shared papers)Shinn‐Zong Lin (9 shared papers)Hong-Lin Su (2 shared papers)Tzyy-Wen Chiou (2 shared papers)Shinn‐Zong Lin (2 shared papers)Tzyy‐Wen Chiou (5 shared papers)Chia‐Yu Chang (2 shared papers)Hong‐Lin Su (3 shared papers)
- Journals
- Cell Transplantation (4 papers)Cancers (2 papers)Molecules (2 papers)Biomicrofluidics (1 paper)Cells (1 paper)
- Partner nations
- TaiwanUnited StatesChina
In The Last Decade
Ching-Ann Liu
15 papers receiving 313 citations
Peers
Comparison fields: 5 of 72
- Developmental Neuroscience 21
- Genetics 46
- Neurology 25
- Molecular Biology 208
- Cancer Research 40
Countries citing papers authored by Ching-Ann Liu
This map shows the geographic impact of Ching-Ann Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ching-Ann Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ching-Ann Liu more than expected).
Fields of papers citing papers by Ching-Ann Liu
This network shows the impact of papers produced by Ching-Ann Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ching-Ann Liu. The network helps show where Ching-Ann Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Ching-Ann Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 83 | |
| 2 | 2020 | 82 | |
| 3 | 2021 | 28 | |
| 4 | 1996 | 27 | |
| 5 | 2015 | 25 | |
| 6 | 2018 | 23 | |
| 7 | 2021 | 15 | |
| 8 | 2018 | 8 | |
| 9 | 2021 | 6 | |
| 10 | 2021 | 5 | |
| 11 | 2022 | 5 | |
| 12 | 2023 | 2 | |
| 13 | 2022 | 2 | |
| 14 | 2021 | 1 | |
| 15 | 2021 | 1 | |
| 16 | 2024 | 0 |
About Ching-Ann Liu
Ching-Ann Liu is a scholar working on Molecular Biology, Genetics, Pulmonary and Respiratory Medicine, Biomedical Engineering and Cellular and Molecular Neuroscience, having authored 16 papers that have together received 313 indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (3 papers), Pluripotent Stem Cells Research (3 papers), Glioma Diagnosis and Treatment (3 papers), Phagocytosis and Immune Regulation (2 papers), Long-Term Effects of COVID-19 (1 paper), Nerve injury and regeneration (1 paper), Neuroscience and Neural Engineering (1 paper) and Nanoplatforms for cancer theranostics (1 paper). The work is most often cited by research in Developmental Neuroscience (21 citations), Genetics (46 citations), Neurology (25 citations), Molecular Biology (208 citations) and Cancer Research (40 citations). Ching-Ann Liu has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Horng‐Jyh Harn, Shinn‐Zong Lin, Hong-Lin Su, Tzyy-Wen Chiou, Shinn‐Zong Lin, Tzyy‐Wen Chiou, Chia‐Yu Chang, Hong‐Lin Su, Tsung‐Jung Ho and Kuan Wang. Their work appears in journals such as Cell Transplantation, Cancers, Molecules, Biomicrofluidics and Cells.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.